- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03313440
Fiber Intake & Fecal Bulk Enhanced Response (Fiber)
July 4, 2018 updated by: Diederik Esser, Wageningen University and Research
Some dietary fibres, including wheat fibres, have shown to increase fecal bulk and improve stool.
In previous studies, this effect on fecal bulk was especially studied for intact wheat fibers.
Moreover, in most studies, the wheat fiber was offered daily as a single dose in cereals.
In this study, we investigate whether an increased intake of extracted wheat fiber, implemented at several time points in a normal daily dietary pattern, can also increase fecal bulk and improve stool frequency and consistency.
Here we want to demonstrate that an increase in VITACEL Wheat Fiber intake will enhance fecal bulk, both wet and dry weight and that the enhanced wheat fiber intake will also increase stool frequency and consistency.
The study is a double-blind crossover design in which the intervention is based on products enriched by VITACEL Wheat Fiber and control products.
Both the control and fiber-enriched intervention will last for 10 days with a wash-out period of at least 4 days.
The study will be conducted with 25 healthy male human volunteers in the age between 18-70 years old.Persons will be assigned to the intervention groups.
In one of the intervention periods participants receive 'control boxes' with products low in wheat fiber and in the other period they will receive boxes with products enriched with VITACEL Wheat Fiber.
During an intervention period of 10 days participants will receive 10 boxes, one for each day.
In the last 5 days of the intervention + 1 additional day after the intervention (so in total 6 days), participants will collect their fecal samples to analyse fecal bulk.
Daily also a diary has to be kept and questionnaires have to be completed to check compliance to the intervention and assess stool consistency, gut-related complaints.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Wageningen, Gelderland, Netherlands, 6708 WG
- Stichting Wageningen Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- Apparently healthy (no gastrointestinal complaints, no food allergies and no medication that can influence the outcome of this study
- Age range between 18-70 years old
- BMI between 20 and 30 kg/m2
- Average fiber intake of <23grams per day
- Living in the surrounding area of Wageningen (radius ~20 km)
Exclusion Criteria:
- Any digestive tract disorder that is expected to interfere with this study (e.g. (partial) gastric resection, (hemi)colectomy, Crohn's disease, ulcerative colitis, irritable bowel disease, Coeliac disease)
- Known food allergy (e.g. lactose, gluten, nuts, egg, etc)
- Vegetarians
- Use of pro- or prebiotics
- Use of medication that can interfere with study outcomes (including laxatives, diuretics, antidepressants, codeine or antibiotics)
- Alcohol intake ≥ 40g/day (≥ 3 glasses of beer/wine per day)
- Drug abuse
- Current smokers
- Participation in other clinical trials in the past month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: high fibre
A 10 day increase in daily wheat fiber intake by 18-22 grams/day.
Products are provided in boxes that must be consumed each day during the intervention.
|
Daily increased fiber intake by 18-22 grams/day.
Products are provided in boxes that must be consumed each day during the intervention.
|
|
Experimental: low fibre
A 10 day control intervention with no additional wheat fibre.
Products are provided in boxes that must be consumed each day during the intervention.
|
Control low fiber intervention.
Products are provided in boxes that must be consumed each day during the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fecal bulk
Time Frame: last 5 days of each intervention period
|
Wet and dry weight of stool samples in grams
|
last 5 days of each intervention period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
stool consistency
Time Frame: last 5 days of each intervention period
|
by Bristol stool chart (type 1-7)
|
last 5 days of each intervention period
|
|
gut-related complaints
Time Frame: last 5 days of each intervention period
|
by questionnaires and Visual Analogue Scale (VAS) scores (on a 90mm horizontal line; from no complains (minimal) to serious complains (maximum)).
Higher values represent a worse outcome
|
last 5 days of each intervention period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Nicole de Wit, Dr, Stichting Wageningen Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2017
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
October 6, 2017
First Submitted That Met QC Criteria
October 12, 2017
First Posted (Actual)
October 18, 2017
Study Record Updates
Last Update Posted (Actual)
July 6, 2018
Last Update Submitted That Met QC Criteria
July 4, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NL62342.081.17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Health
-
Bright Dairy & Food Co., LtdCompletedIntestinal HealthChina
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedIntestinal HealthUnited States
-
Wecare Probiotics Co., Ltd.Not yet recruitingIntestinal HealthChina
-
Norwegian University of Life SciencesUniversity of Oslo; Norwegian School of Sport Sciences; Norwegian Olympic Sports...Active, not recruitingAthletes | Endurance Performance | Microbiota | Iron | Hemoglobin | Intestinal HealthNorway
-
University of LjubljanaUniversity Medical Centre LjubljanaCompletedBody Composition | Breastfeeding | Health | Intestinal Microbiota | Dietary IntakeSlovenia
-
Laval UniversityCompletedMental Health Wellness 1 | Food Habits | Intestinal Disease | Energy MetabolismCanada
-
Qu ShenNot yet recruiting
-
University of Southern CaliforniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingColorectal Cancer | Health Behavior | Healthy Lifestyle | Behavior, Health | Gastrointestinal CancersUnited States
-
The Royal Wolverhampton Hospitals NHS TrustNot yet recruitingInflammatory Bowel Diseases | Mental Health IssueUnited Kingdom
Clinical Trials on High wheat fiber
-
Purdue UniversityCompletedObesity | Dietary Modification | Lack of Satiety | Memory DeficitsUnited States
-
Örebro University, SwedenUniversity of Helsinki; European Innovation CouncilRecruitingHealthy Adults | Dietary Fiber FermentationSweden
-
University of Texas Southwestern Medical CenterCompletedNon-Insulin-Dependent Diabetes Mellitus
-
University of Missouri-ColumbiaCompleted
-
BeachbodyGlycemic Index Laboratories, IncCompletedOverweight and ObesityCanada
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedPrimary Biliary CirrhosisMexico
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedCirrhosis | Autoimmune HepatitisMexico
-
China Medical University HospitalUnknownImpaired Glucose ToleranceTaiwan